US 11666602
Treatment of pulmonary arterial hypertension with mesenchymal stem cells
granted A61KA61K2035/124A61K31/192
Quick answer
US patent 11666602 (Treatment of pulmonary arterial hypertension with mesenchymal stem cells) held by United Therapeutics Corporation expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United Therapeutics Corporation
- Grant date
- Tue Jun 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2035/124, A61K31/192, A61K31/5585, A61K35/15